Value of diffusion kurtosis MR imaging and conventional diffusion weighed imaging for evaluating response to first-line chemotherapy in unresectable pancreatic cancer

Abstract Objective To investigate the diagnostic value of diffusion kurtosis magnetic resonance imaging (DKI) and conventional diffusion-weighted imaging (DWI) for evaluating the response to first-line chemotherapy in unresectable pancreatic cancer. Materials and methods We retrospectively analyzed...

Full description

Bibliographic Details
Main Authors: Zehua Zhang, Yuqin Zhang, Feixiang Hu, Tiansong Xie, Wei Liu, Huijing Xiang, Xiangxiang Li, Lei Chen, Zhengrong Zhou
Format: Article
Language:English
Published: BMC 2024-02-01
Series:Cancer Imaging
Subjects:
Online Access:https://doi.org/10.1186/s40644-024-00674-y
_version_ 1827326416097640448
author Zehua Zhang
Yuqin Zhang
Feixiang Hu
Tiansong Xie
Wei Liu
Huijing Xiang
Xiangxiang Li
Lei Chen
Zhengrong Zhou
author_facet Zehua Zhang
Yuqin Zhang
Feixiang Hu
Tiansong Xie
Wei Liu
Huijing Xiang
Xiangxiang Li
Lei Chen
Zhengrong Zhou
author_sort Zehua Zhang
collection DOAJ
description Abstract Objective To investigate the diagnostic value of diffusion kurtosis magnetic resonance imaging (DKI) and conventional diffusion-weighted imaging (DWI) for evaluating the response to first-line chemotherapy in unresectable pancreatic cancer. Materials and methods We retrospectively analyzed 21 patients with clinically and pathologically confirmed unresected pancreatic cancer who received palliative chemotherapy. Three-tesla MRI examinations containing DWI sequences with b values of 0, 100, 700, 1400, and 2100 s/mm2 were performed before and after chemotherapy. Parameters included the apparent diffusion coefficient (ADC), mean diffusion coefficient (MD), and mean diffusional kurtosis (MK). The performances of the DWI and DKI parameters in distinguishing the response to chemotherapy were evaluated by the area under the curve (AUC) of the receiver operating characteristic (ROC) curve. Overall survival (OS) was calculated from the date of first treatment to the date of death or the latest follow-up date. Results The ADCchange and MDchange were significantly higher in the responding group (PR group) than in the nonresponding group (non-PR group) (ADCchange: 0.21 ± 0.05 vs. 0.11 ± 0.09, P = 0.02; MDchange: 0.37 ± 0.24 vs. 0.10 ± 0.12, P = 0.002). No statistical significance was shown when comparing ADCpre, ADCpost, MKpre, MKpost, MKchange, MDpre, and MDpost between the PR and non-PR groups. The ROC curve analysis indicated that MDchange (AUC = 0.898, cutoff value = 0.7143) performed better than ADCchange (AUC = 0.806, cutoff value = 0.1369) in predicting the response to chemotherapy. Conclusion The ADCchange and MDchange demonstrated strong potential for evaluating the response to chemotherapy in unresectable pancreatic cancer. The MDchange showed higher specificity in the classification of PR and non-PR than the ADCchange. Other parameters, including ADCpre, ADCpost, MKpre, MKpost, MKchange, MDpre, and MDpost, are not suitable for response evaluation. The combined model SUMchange demonstrated superior performance compared to the individual DWI and DKI models. Further experiments are needed to evaluate the potential of DWI and DKI parameters in predicting the prognosis of patients with unresectable pancreatic cancer.
first_indexed 2024-03-07T14:44:10Z
format Article
id doaj.art-efa77f4dec4b4dab8c1f5587433f5c29
institution Directory Open Access Journal
issn 1470-7330
language English
last_indexed 2024-03-07T14:44:10Z
publishDate 2024-02-01
publisher BMC
record_format Article
series Cancer Imaging
spelling doaj.art-efa77f4dec4b4dab8c1f5587433f5c292024-03-05T20:08:16ZengBMCCancer Imaging1470-73302024-02-012411910.1186/s40644-024-00674-yValue of diffusion kurtosis MR imaging and conventional diffusion weighed imaging for evaluating response to first-line chemotherapy in unresectable pancreatic cancerZehua Zhang0Yuqin Zhang1Feixiang Hu2Tiansong Xie3Wei Liu4Huijing Xiang5Xiangxiang Li6Lei Chen7Zhengrong Zhou8Department of Radiology, Minhang Branch, Fudan University Shanghai Cancer CenterDepartment of Colorectal Surgery, Minhang Branch, Fudan University Shanghai Cancer CenterDepartment of Radiology, Fudan University Shanghai Cancer CenterDepartment of Radiology, Fudan University Shanghai Cancer CenterDepartment of Radiology, Fudan University Shanghai Cancer CenterDepartment of Radiology, Minhang Branch, Fudan University Shanghai Cancer CenterNursing department, Minhang Branch, Fudan University Shanghai Cancer CenterDepartment of Radiology, Minhang Branch, Fudan University Shanghai Cancer CenterDepartment of Radiology, Minhang Branch, Fudan University Shanghai Cancer CenterAbstract Objective To investigate the diagnostic value of diffusion kurtosis magnetic resonance imaging (DKI) and conventional diffusion-weighted imaging (DWI) for evaluating the response to first-line chemotherapy in unresectable pancreatic cancer. Materials and methods We retrospectively analyzed 21 patients with clinically and pathologically confirmed unresected pancreatic cancer who received palliative chemotherapy. Three-tesla MRI examinations containing DWI sequences with b values of 0, 100, 700, 1400, and 2100 s/mm2 were performed before and after chemotherapy. Parameters included the apparent diffusion coefficient (ADC), mean diffusion coefficient (MD), and mean diffusional kurtosis (MK). The performances of the DWI and DKI parameters in distinguishing the response to chemotherapy were evaluated by the area under the curve (AUC) of the receiver operating characteristic (ROC) curve. Overall survival (OS) was calculated from the date of first treatment to the date of death or the latest follow-up date. Results The ADCchange and MDchange were significantly higher in the responding group (PR group) than in the nonresponding group (non-PR group) (ADCchange: 0.21 ± 0.05 vs. 0.11 ± 0.09, P = 0.02; MDchange: 0.37 ± 0.24 vs. 0.10 ± 0.12, P = 0.002). No statistical significance was shown when comparing ADCpre, ADCpost, MKpre, MKpost, MKchange, MDpre, and MDpost between the PR and non-PR groups. The ROC curve analysis indicated that MDchange (AUC = 0.898, cutoff value = 0.7143) performed better than ADCchange (AUC = 0.806, cutoff value = 0.1369) in predicting the response to chemotherapy. Conclusion The ADCchange and MDchange demonstrated strong potential for evaluating the response to chemotherapy in unresectable pancreatic cancer. The MDchange showed higher specificity in the classification of PR and non-PR than the ADCchange. Other parameters, including ADCpre, ADCpost, MKpre, MKpost, MKchange, MDpre, and MDpost, are not suitable for response evaluation. The combined model SUMchange demonstrated superior performance compared to the individual DWI and DKI models. Further experiments are needed to evaluate the potential of DWI and DKI parameters in predicting the prognosis of patients with unresectable pancreatic cancer.https://doi.org/10.1186/s40644-024-00674-yDiffusion kurtosis imagingApparent diffusion coefficientUnresectable pancreatic cancerFirst-line chemotherapy
spellingShingle Zehua Zhang
Yuqin Zhang
Feixiang Hu
Tiansong Xie
Wei Liu
Huijing Xiang
Xiangxiang Li
Lei Chen
Zhengrong Zhou
Value of diffusion kurtosis MR imaging and conventional diffusion weighed imaging for evaluating response to first-line chemotherapy in unresectable pancreatic cancer
Cancer Imaging
Diffusion kurtosis imaging
Apparent diffusion coefficient
Unresectable pancreatic cancer
First-line chemotherapy
title Value of diffusion kurtosis MR imaging and conventional diffusion weighed imaging for evaluating response to first-line chemotherapy in unresectable pancreatic cancer
title_full Value of diffusion kurtosis MR imaging and conventional diffusion weighed imaging for evaluating response to first-line chemotherapy in unresectable pancreatic cancer
title_fullStr Value of diffusion kurtosis MR imaging and conventional diffusion weighed imaging for evaluating response to first-line chemotherapy in unresectable pancreatic cancer
title_full_unstemmed Value of diffusion kurtosis MR imaging and conventional diffusion weighed imaging for evaluating response to first-line chemotherapy in unresectable pancreatic cancer
title_short Value of diffusion kurtosis MR imaging and conventional diffusion weighed imaging for evaluating response to first-line chemotherapy in unresectable pancreatic cancer
title_sort value of diffusion kurtosis mr imaging and conventional diffusion weighed imaging for evaluating response to first line chemotherapy in unresectable pancreatic cancer
topic Diffusion kurtosis imaging
Apparent diffusion coefficient
Unresectable pancreatic cancer
First-line chemotherapy
url https://doi.org/10.1186/s40644-024-00674-y
work_keys_str_mv AT zehuazhang valueofdiffusionkurtosismrimagingandconventionaldiffusionweighedimagingforevaluatingresponsetofirstlinechemotherapyinunresectablepancreaticcancer
AT yuqinzhang valueofdiffusionkurtosismrimagingandconventionaldiffusionweighedimagingforevaluatingresponsetofirstlinechemotherapyinunresectablepancreaticcancer
AT feixianghu valueofdiffusionkurtosismrimagingandconventionaldiffusionweighedimagingforevaluatingresponsetofirstlinechemotherapyinunresectablepancreaticcancer
AT tiansongxie valueofdiffusionkurtosismrimagingandconventionaldiffusionweighedimagingforevaluatingresponsetofirstlinechemotherapyinunresectablepancreaticcancer
AT weiliu valueofdiffusionkurtosismrimagingandconventionaldiffusionweighedimagingforevaluatingresponsetofirstlinechemotherapyinunresectablepancreaticcancer
AT huijingxiang valueofdiffusionkurtosismrimagingandconventionaldiffusionweighedimagingforevaluatingresponsetofirstlinechemotherapyinunresectablepancreaticcancer
AT xiangxiangli valueofdiffusionkurtosismrimagingandconventionaldiffusionweighedimagingforevaluatingresponsetofirstlinechemotherapyinunresectablepancreaticcancer
AT leichen valueofdiffusionkurtosismrimagingandconventionaldiffusionweighedimagingforevaluatingresponsetofirstlinechemotherapyinunresectablepancreaticcancer
AT zhengrongzhou valueofdiffusionkurtosismrimagingandconventionaldiffusionweighedimagingforevaluatingresponsetofirstlinechemotherapyinunresectablepancreaticcancer